Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Zhejiang Wecome Pharmaceutical Company financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥17.3

2024-10-29

Market Capitalization

¥2.4 B

2024-10-29

Revenue

¥335.3 M

FY, 2024

CreditSafe Score

?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024
Revenue571.0M635.6M618.3M626.4M526.4M511.8M335.3M
Cost of goods sold142.3M167.8M171.4M204.4M220.1M257.1M217.1M
Gross profit428.9M468.8M447.9M423.8M309.3M259.7M122.4M
Gross profit margin, %75.1%73.8%72.4%67.7%58.8%50.8%36.5%
Operating expense total330.2M341.0M304.8M296.9M237.4M245.4M217.4M
Depreciation and amortization12.1M35.0M31.2M46.8M142.5M
EBITDA98.7M127.9M143.1M126.9M72.0M14.2M(95.0M)
EBITDA margin, %17.3%20.1%23.1%20.3%13.7%2.8%-28.3%
EBIT104.8M147.6M153.4M96.7M51.0M(11.7M)(243.1M)
EBIT margin, %18.3%23.2%24.8%15.4%9.7%-2.3%-72.5%
Interest income236.0K1.2M5.6M5.3M2.2M2.0M3.1M
Interest expense1.4M1.0M253.0K2.2M5.4M9.5M9.3M
Pre tax profit103.4M147.6M158.7M100.0M57.8M(6.7M)(158.3M)
Income tax expense15.6M21.6M23.0M3.5M12.6M424.0K(13.4M)
Net Income87.8M126.0M135.7M96.5M45.1M(7.1M)(144.9M)

Footer menu